In December 2020, Swedish Medical Technologies Product (MTP) Council decided to evaluate new technologies for self-monitoring of atrial fibrillation within the Orderly introduction framework.
This framework aimed to manage the national introduction of novel technologies is working as permanent from the beginning of 2020. This is a staged process, including horizon scanning, selection of the method for evaluation, the decision on national collaboration, health economic evaluation, and recommendations by MTP Council to regions about the introduction of the method and criteria for use.
In Summer 2020, Swedish Dental and Pharmaceutical Benefits Agency (TLV) conducted a thematic survey in the cardiovascular area as a part of horizon scanning within the Orderly introduction framework, which provided information on products that the MTP Council has now found interesting to proceed with.
MTP Council commissioned TLV to perform a health-economic evaluation of Coala Heart Monitor Pro and KardiaMobile in which patients can register their ECG and send it to a healthcare provider. Other products may also be considered at a later point.
Based on the results of the health-economic evaluation, the MTP Council will then make recommendations to the regions on whether to adopt these technologies or not.
See more information in Swedish here.
This news is just one of about 300 market access news collected by our team in the subscription services "HTA Alerts” and “Reimbursement Alerts” every two weeks from more than 80 organizations. Access our paid subscription services to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news). First EU issues of both newsletters are available for download free-of-charge.
Not ready for a subscription service? Subscribe to our free-of-charge newsletter delivered every second week to get updates about key reimbursement developments in Europe (10-12 news every two weeks).